Literature DB >> 8282018

Benzodiazepine receptor equilibrium constants for flumazenil and midazolam determined in humans with the single photon emission computer tomography tracer [123I]iomazenil.

C Videbaek1, L Friberg, S Holm, S Wammen, C Foged, J V Andersen, L Dalgaard, N A Lassen.   

Abstract

This study is based on the steady state method for the calculation of Kd values recently described by Lassen (J. Cereb. Blood Flow Metab. 12 (1992), 709), in which a constant infusion of the examined nonradioactive ligand is used with a bolus injection of tracer. Eight volunteers were examined twice, once without receptor blockade and once with a constant degree of partial blockade of the benzodiazepine receptors by infusion of nonradioactive flumazenil (Lanexat) or midazolam (Dormicum). Single photon emission computer tomography and blood sampling were performed intermittently for 6 h after bolus injection of [123I]iomazenil. The tracer in plasma was determined by high-pressure liquid chromatography and also by a simple octanol extraction procedure. The free concentration of flumazenil and midazolam in plasma water averaged 52% and 3.5% of that in whole plasma. The Kd values for the entire cortical rim for flumazenil were 7.4, 10.0, 10.3 and 17.7 nmol/l plasma water and, for midazolam, 73, 76, 58 and 30 nmol/l plasma water. The variation exceeds random methodological error and is probably due to interindividual differences in receptor affinity. The Kd level of midazolam is considerably higher than expected from the results of in vitro studies.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8282018     DOI: 10.1016/0014-2999(93)90660-a

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  7 in total

1.  Euphorigenic doses of cocaine reduce [123I]beta-CIT SPECT measures of dopamine transporter availability in human cocaine addicts.

Authors:  R T Malison; S E Best; E A Wallace; E McCance; M Laruelle; S S Zoghbi; R M Baldwin; J S Seibyl; P B Hoffer; L H Price
Journal:  Psychopharmacology (Berl)       Date:  1995-12       Impact factor: 4.530

2.  Reduced cortical distribution volume of iodine-123 iomazenil in Alzheimer's disease as a measure of loss of synapses.

Authors:  A Soricelli; A Postiglione; M R Grivet-Fojaja; P P Mainenti; A Discepolo; A Varrone; M Salvatore; N A Lassen
Journal:  Eur J Nucl Med       Date:  1996-10

3.  Benzodiazepine receptor quantification in Huntington's disease with [(123)I]omazenil and SPECT.

Authors:  L H Pinborg; C Videbaek; S G Hasselbalch; S A Sørensen; A Wagner; O B Paulson; G M Knudsen
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-05       Impact factor: 10.154

4.  A reappraisal of the relative merits of SPET and PET in the quantitation of neuroreceptors: the advantage of a longer half-life!

Authors:  N A Lassen
Journal:  Eur J Nucl Med       Date:  1996-01

5.  GABA-benzodiazepine receptor function in alcohol dependence: a combined 11C-flumazenil PET and pharmacodynamic study.

Authors:  A R Lingford-Hughes; S J Wilson; V J Cunningham; A Feeney; B Stevenson; D J Brooks; D J Nutt
Journal:  Psychopharmacology (Berl)       Date:  2005-04-28       Impact factor: 4.530

6.  Characterisation of the contribution of the GABA-benzodiazepine α1 receptor subtype to [(11)C]Ro15-4513 PET images.

Authors:  James F M Myers; Lula Rosso; Ben J Watson; Sue J Wilson; Nicola J Kalk; Nicoletta Clementi; David J Brooks; David J Nutt; Federico E Turkheimer; Anne R Lingford-Hughes
Journal:  J Cereb Blood Flow Metab       Date:  2012-01-04       Impact factor: 6.200

Review 7.  Selective neuronal loss in ischemic stroke and cerebrovascular disease.

Authors:  Jean-Claude Baron; Hiroshi Yamauchi; Masayuki Fujioka; Matthias Endres
Journal:  J Cereb Blood Flow Metab       Date:  2013-11-06       Impact factor: 6.200

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.